Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC
25 November 2003 - 4:14AM
PR Newswire (US)
Schatz & Nobel, P.C. Provides Update to Biovail Investors who
Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC
Investigation of Biovail and Class Action Lawsuit HARTFORD, Conn.,
Nov. 24 /PRNewswire/ -- The November 21, 2003 edition of the Wall
Street Journal reports that the Securities and Exchange Commission
has opened an informal inquiry into Biovail relating to its
accounting and financial reporting practices for fiscal 2002 and
fiscal 2003 to date, and that the SEC has requested a copy of a
report issued by a securities analyst who questioned Defendant
Eugene N. Melnyk during a Biovail conference call on October 30,
2003 about Mr. Melnyk's securities transactions. Schatz & Nobel
wishes to inform Biovail investors that a lawsuit seeking class
action status has been filed in the United States District Court
for the Southern District of New York on behalf of persons who
purchased the common shares of Biovail Corporation (NYSE: BVF; TSX:
BVF) ("Biovail" or the "Company") for violations of the federal
securities laws, and alleges, inter alia, that the reports issued
by Biovail concerning its 2002 and 2003 financial results were
materially false and misleading and overstated Biovail's revenue
and earnings. Schatz & Nobel, P.C. has significant experience
prosecuting class actions on behalf of investors. If you wish to
discuss the class action or have any questions, please contact
attorney Andrew M. Schatz, Jeffrey S. Nobel, or Nancy A. Kulesa at
(800) 797-5499, or by e-mail at . For more information about Schatz
& Nobel, P.C. and class action cases, please visit our website:
http://www.snlaw.net/. Biovail's common shares are traded on the
New York Stock Exchange and on the Toronto Stock Exchange under the
symbol "BVF." Schatz & Nobel, P.C. seeks to recover damages on
behalf of all Class Members, including Class Members that purchased
Biovail common shares on the New York Stock Exchange and/or the
Toronto Stock Exchange. If you purchased or otherwise acquired
Biovail common shares between May 17, 2002 and October 30, 2003,
and wish to act as a lead plaintiff, you may move the Court to act
in that capacity not later than January 12, 2004. If you wish to
discuss your rights as lead plaintiff or as a class member, please
contact Schatz & Nobel, P.C. toll-free at (800) 797-5499, or by
e-mail at . CONTACT: Andrew M. Schatz Jeffrey S. Nobel Nancy A.
Kulesa Tel.: (800) 797-5499 Website: http://www.snlaw.net/ e-mail:
DATASOURCE: Schatz & Nobel, P.C. CONTACT: Andrew M. Schatz or
Jeffrey S. Nobel or Nancy A. Kulesa, +1-800-797-5499, , all of
Schatz & Nobel, P.C. Web site: http://www.snlaw.net/
Copyright